title: How should we be funding costly drugs?
authors.forename: Jonathan
authors.initials: J
authors.lastname: Dawes
mesh_terms: D002202:Capital Financing / Q000379:methods*; D004358:Drug Therapy / Q000191:economics*; D006801:Humans; D013222:State Medicine; D006113:United Kingdom